Bay of Plenty Times
  • Bay of Plenty Times home
  • Latest news
  • Business
  • Opinion
  • Lifestyle
  • Property
  • Sport
  • Video
  • Death notices
  • Classifieds

Subscriptions

  • Herald Premium
  • Viva Premium
  • The Listener
  • BusinessDesk

Sections

  • Latest news
  • On The Up
  • Business
  • Opinion
  • Lifestyle
  • Property
    • All Property
    • Residential property listings
  • Rural
    • All Rural
    • Dairy farming
    • Sheep & beef farming
    • Horticulture
    • Animal health
    • Rural business
    • Rural life
    • Rural technology
  • Sport

Locations

  • Coromandel & Hauraki
  • Katikati
  • Tauranga
  • Mount Maunganui
  • Pāpāmoa
  • Te Puke
  • Whakatāne
  • Rotorua

Media

  • Video
  • Photo galleries
  • Today's Paper - E-Editions
  • Photo sales
  • Classifieds

Weather

  • Thames
  • Tauranga
  • Whakatāne
  • Rotorua

NZME Network

  • Advertise with NZME
  • OneRoof
  • Driven Car Guide
  • BusinessDesk
  • Newstalk ZB
  • Sunlive
  • ZM
  • The Hits
  • Coast
  • Radio Hauraki
  • The Alternative Commentary Collective
  • Gold
  • Flava
  • iHeart Radio
  • Hokonui
  • Radio Wanaka
  • iHeartCountry New Zealand
  • Restaurant Hub
  • NZME Events

SubscribeSign In
Advertisement
Advertise with NZME.
Home / Bay of Plenty Times

The Premium Debate: Subscribers have their say on Trikafta drug for cystic fibrosis

Rotorua Daily Post
6 Apr, 2022 09:00 PM3 mins to read

Subscribe to listen

Access to Herald Premium articles require a Premium subscription. Subscribe now to listen.
Already a subscriber?  Sign in here

Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech.
‌
Save

    Share this article

    Reminder, this is a Premium article and requires a subscription to read.

Ashley Watson has access to Trikafta for his cystic fibrosis while his brother Troy, who suffers from the same condition, can't because he is "too well". Photo / Andrew Warner

Ashley Watson has access to Trikafta for his cystic fibrosis while his brother Troy, who suffers from the same condition, can't because he is "too well". Photo / Andrew Warner

OPINION


Two Bay brothers suffer from cystic fibrosis. Ashley Watson gets Trikafta free through a compassionate managed access programme funded by the drug's manufacturer and supplier. He said it had been a "miracle". His brother Troy, however, was "too well" to be eligible. Troy said he asked his specialist about
it but was told there was "no chance" for someone like him without government funding.

My friend's daughter has been on Trikafta for about 18 months to two years in the US and it has changed her life. She is now enjoying life at university just like any other 21-year-old. It's heartbreaking to hear stories like this when you know how much it will improve the quality of life for people with cystic fibrosis.
Angela H

Why is it so expensive? excessive profits?
Terry O

In reply to Terry O
Because it costs a fortune to develop and these costs are spread over a small number of users when compared to other drugs which treat large numbers of sufferers.
Jean G

Advertisement
Advertise with NZME.

Read more: Cystic fibrosis: Why one brother can get Trikafta and the other can't

This Government has a lot of explaining to do. During Covid there were billions of dollars flying around to keep people employed and businesses from failing. They can never have an excuse for lack of funding for Pharmac because we know the money is there.
Mohammed S

How wrong is it that in New Zealand our families have to be put in this avoidable situation? Pharmac is so underfunded that NZ is at the bottom of the OECD in terms of medicine funding. Trikafta clearly saves lives, and keeping people well enough so that they stay out of hospital and well enough to start working makes this a no-brainer as it will likely save the health system money in the long run.
Edward L

Advertisement
Advertise with NZME.

A very sad story. As a country we need to get our priorities right. Just imagine how many people we could have treated with the money wasted on reports such as the Auckland Cycle Way.
David P

Maybe someone can ask the manufacturer why it is so expensive to supply. This drug is sold around the world. Does everyone pay the same price? Can we get a better price if we order (and pay the proportional share) if we combine our orders with Australia?
Are the drug companies ripping off the sick? It must cost millions to develop so why charge exorbitant costs for decades after it is released to market?
Robert M

Discover more

Opinion

Opinion: Not wanted or valued by Labour - I don't blame Louisa Wall for leaving politics

05 Apr 10:00 PM
New Zealand

Jo Raphael: Women exercising alone should not face safety threats

03 Apr 10:00 PM
Kahu

Ngahi Bidois: Stay focused as you embrace the challenge of change

01 Apr 09:00 PM

If, from a government perspective, treating this young man is all about the money, I would have thought economically there was great value in treating a 20-year-old so that he doesn't get sicker, and can then lead a productive life. As for how sad this is, I can only say I admire his courage, and that of his family.
Jennifer P

What a gut-wrenching story about Troy and Ashley. The priorities of spending of this Labour govt makes me numb. Aborted cycle bridge, lunches in schools, socialist reforms every which way - surely the priority of this or any government must be to look after our own in the form of decent medical treatment.
What could be more important?
Paul C

- Republished comments may be edited at the editor's discretion.

Save

    Share this article

    Reminder, this is a Premium article and requires a subscription to read.

Latest from Bay of Plenty Times

Bay of Plenty Times

Graeme Dingle leader steps back after 25 years, will still lead Project K

21 Jun 02:00 AM
Bay of Plenty Times

'Max capacity': Good news for growing school squeezing classes into library

20 Jun 09:00 PM
Bay of Plenty Times

Tauranga couple's 'amazing journey' to parenthood

20 Jun 05:00 PM

Jono and Ben brew up a tea-fuelled adventure in Sri Lanka

sponsored
Advertisement
Advertise with NZME.

Latest from Bay of Plenty Times

Graeme Dingle leader steps back after 25 years, will still lead Project K

Graeme Dingle leader steps back after 25 years, will still lead Project K

21 Jun 02:00 AM

He founded Kiwi Can in Ōpōtiki and Tauranga, reaching over 3700 youth weekly.

'Max capacity': Good news for growing school squeezing classes into library

'Max capacity': Good news for growing school squeezing classes into library

20 Jun 09:00 PM
Tauranga couple's 'amazing journey' to parenthood

Tauranga couple's 'amazing journey' to parenthood

20 Jun 05:00 PM
My father was a community hero - he also sexually abused me

My father was a community hero - he also sexually abused me

20 Jun 05:00 PM
Help for those helping hardest-hit
sponsored

Help for those helping hardest-hit

NZ Herald
  • About NZ Herald
  • Meet the journalists
  • Newsletters
  • Classifieds
  • Help & support
  • Contact us
  • House rules
  • Privacy Policy
  • Terms of use
  • Competition terms & conditions
  • Our use of AI
Subscriber Services
  • Bay of Plenty Times e-edition
  • Manage your print subscription
  • Manage your digital subscription
  • Subscribe to Herald Premium
  • Subscribe to the Bay of Plenty Times
  • Gift a subscription
  • Subscriber FAQs
  • Subscription terms & conditions
  • Promotions and subscriber benefits
NZME Network
  • Bay of Plenty Times
  • The New Zealand Herald
  • The Northland Age
  • The Northern Advocate
  • Waikato Herald
  • Rotorua Daily Post
  • Hawke's Bay Today
  • Whanganui Chronicle
  • Viva
  • NZ Listener
  • Newstalk ZB
  • BusinessDesk
  • OneRoof
  • Driven Car Guide
  • iHeart Radio
  • Restaurant Hub
NZME
  • About NZME
  • NZME careers
  • Advertise with NZME
  • Digital self-service advertising
  • Book your classified ad
  • Photo sales
  • NZME Events
  • © Copyright 2025 NZME Publishing Limited
TOP